AzTrials
AzTrials

Dementia CaregiverNCT07444866

Machine Learning Enabled Management of Behavioural and Psychological Symptoms of Dementia Intervention for Dementia Caregivers

A study testing Behavioral: Continue, Behavioral: Enhance human coaching and Behavioral: Booster in people with Dementia Caregiver, run by Education University of Hong Kong at 1 site in Hong Kong.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Develop and test a machine learning enabled management of behavioural and psychological symptoms of dementia intervention for dementia caregivers. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Dementia Caregiver
What is being tested?
Behavioral: Continue, Behavioral: Enhance human coaching and Behavioral: Booster
Could I receive a placebo?
No, everyone receives an active treatment
How many people
550 participants
Where
1 siteHong Kong
Study dates
12 Oct 2026to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • aged 18 above
  • family caregiver of an individual with a confirmed medical diagnosis of any type of dementia who has been residing in the community
  • having been providing care for ADLs and IADLs for at least 20 hours per week for at least one year prior to recruitment
  • have a smartphone
  • have mild to moderate stress (the 14-item Chinese version Perceived Stress Scale).

Who cannot join

  • having participated in any structured mind-body intervention, cognitive therapy, or structured psychosocial intervention in the 6 months prior to recruitment
  • having acute psychiatric and medical comorbidities that are potentially life-threatening (e.g. suicidal ideation) or that limit the caregivers' participation or adherence (e.g. acute psychosis)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hong Kong1 site
  • The Education University of Hong Kong

    Hong Kong

    Kee Lee Chou, PhD, +85229487473, klchou@eduhk.hk

    Vivien Tang, MSc, s1135125@s.eduhk.hk

Other trials in Hong Kong

About this study

Official title: Developing and Testing a Machine Learning Enabled Management of Behavioural and Psychological Symptoms of Dementia Intervention for Dementia Caregivers: A Hybrid Experimental Design Study

Develop and test a machine learning enabled management of behavioural and psychological symptoms of dementia intervention for dementia caregivers.

Being tested
Active Control, Behavioral: Continue, Behavioral: Enhance human coaching, Behavioral: Booster
Keywords
Hybrid factorial - Sequential Multiple Assignment Randomized Trial, Micro Randomized Trial experimental design, machine learning, intervention, dementia caregiver

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active ControlBehavioural

    No APP based coaching, no human coaching, no rerandomization, no MRT

  • Behavioral: ContinueBehavioural

    Continue with existing intervention plan

  • Behavioral: Enhance human coachingBehavioural

    Increase intensity of human coaching

  • Behavioral: BoosterBehavioural

    Add a booster session

Study groups in NCT07444866
Study groupRoleWhat they receive
Active controlActive comparatorActive control
Receives: Behavioral: Active Control
App & Human Coaching + Continue InterventionExperimentalFirst-line of coaching: App + Human Coaching Responder
Receives: Behavioral: Behavioral: Continue
App & Human Coaching + Increase intensity in human coachingExperimentalFirst-line of coaching: App + Human Coaching Non-Responder
Receives: Behavioral: Behavioral: Enhance human coaching
App & Human Coaching + BoosterExperimentalFirst-line of coaching: App + Human Coaching Non-Responder
Receives: Behavioral: Behavioral: Booster
App Coaching + Continue InterventionExperimentalFirst-line of coaching: App Coaching Responder
Receives: Behavioral: Behavioral: Continue
App Coaching + Increase intensity in human coachingExperimentalFirst-line of coaching: App Coaching Non-Responder
Receives: Behavioral: Behavioral: Enhance human coaching
App Coaching + BoosterExperimentalFirst-line of coaching: App Coaching Non-Responder
Receives: Behavioral: Behavioral: Booster
Human Coaching + Continue InterventionExperimentalFirst-line of coaching: Human Coaching Responder
Receives: Behavioral: Behavioral: Continue
Human Coaching + Increase intensity in human coachingExperimentalFirst-line of coaching: Human Coaching Non-Responder
Receives: Behavioral: Behavioral: Enhance human coaching
Human Coaching + BoosterExperimentalFirst-line of coaching: Human Coaching Non-Responder
Receives: Behavioral: Behavioral: Booster
No Coaching + Continue InterventionExperimentalFirst-line of coaching: No Coaching Responder
Receives: Behavioral: Behavioral: Continue
No Coaching + Increase intensity in human coachingExperimentalFirst-line of coaching: No Coaching Non-Responder
Receives: Behavioral: Behavioral: Enhance human coaching
No Coaching + BoosterExperimentalFirst-line of coaching: No Coaching Non-Responder
Receives: Behavioral: Behavioral: Booster

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stress

    10-item Perceived Stress Scale; each item will be rated from 0=Never to 4=Very often. Total scores range from 0 to 40.

    Measured: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)

Secondary outcomes (12)
  1. Depression

    Patient Health Questionnaire-9; Each item will be rated from 0=Not at all to 3=nearly everyday. Total scores range from 0 to 27

    Measured: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)

  2. Sleep Quality

    Pittsburgh Sleep Quality Index; each item will be rated from 0=No difficulty to 3=Severe difficulty. Total scores range from 0 to 21. Higher scores indicating poorer sleep quality

    Measured: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)

  3. Anxiety

    Generalised Anxiety Disorder; each item will be rated from 0=not at all to 3=nearly every day. Total score range from 0 to 21.

    Measured: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)

  4. Physical Health

    Lawton Instrumental Activities of Daily Living; each item will be rated 0=dependent to 1=independent. Total scores range from 0 to 8.

    Measured: Baseline (T0), 32 weeks after baseline assessment (T4)

  5. Physical Health

    Activities of Daily Living; each item will be rate from 0=dependent to 5/10=independent. Total scores range from 0 to 100.

    Measured: Baseline (T0), 32 weeks after baseline assessment (T4)

  6. Physical Symptoms

    Wahler Physical Symptoms Inventory; each item will be rated from 0=almost never agree to 5=agree almost every day. Total score range from 0 to 210.

    Measured: Baseline (T0), 32 weeks after baseline assessment (T4)

  7. Chronic Illness

    Participants will indicate any presence of chronic illness (e.g., diabetes, asthma, high blood pressure).

    Measured: Baseline (T0), 32 weeks after baseline assessment (T4)

  8. Caregiver Burden

    12-item Zarit Burden Interview Scale ; each item will be rated from 0=Never to 4=Nearly always. Total scores range from 0 to 48.

    Measured: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)

  9. Psychological Well-Being

    18-item Ryff Psychological Well-Being scale, each item range from 1-strongly agree to 7-strongly disagree. Total score range from 18-126.

    Measured: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)

  10. Physical and Mental Health

    5-level EQ-5D version (EQ-5D-5L) will be utilized; the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).

    The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

    The EQ VAS records the patient's self-rated health on a vertical visual analogue scale where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome that reflects

    Measured: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)

  11. Neuropsychiatric

    Neuropsychiatric Inventory Questionnaire; classified each of the 12 domain into presence of symptom, frequency, severity, and caregiver distress.

    Measured: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)

  12. Memory and Behaviour Problems

    Revised Memory and Behavior Problems Checklist; a 24-item checklist from 0=never occurred/not at all to 4=daily/extremely. Higher score indicate more frequent behavioral problems/caregiver distress

    Measured: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2026
  2. Study start12 Oct 2026 (estimated)
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Model description
Hybrid factorial - Sequential Multiple Assignment Randomized Trial (SMART), Micro Randomized Trial (MRT) experimental design with a 2x2+1 factorial design (with five arms) randomized clinical trial, 2 stage SMART and three MRTs
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
550 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07444866
Sponsor's protocol ID
2023-2024-0387
Other IDs
22231921
Status last verified
Sep 2026
First submitted
25 Feb 2026
Last updated
5 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Cheung DSK, Kor PPK, Chu AMY, Xie H, Qian M, Chu LW, Zarit S, Chou KL. Machine learning-enabled behavioural and psychological symptoms of dementia management intervention for dementia caregivers: protocol for a hybrid factorial SMART-MRT trial. BMC Geriatr. 2026 Jul 13. doi: 10.1186/s12877-026-07894-w. Online ahead of print.

    PubMed 42443790

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral: Continue, Behavioral: Enhance human coaching and Behavioral: Booster in people with Dementia Caregiver, run by Education University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stress (time frame: Baseline (T0), 6 weeks after baseline assessment (T1), 10 weeks after baseline assessment (T2), 20 weeks after baseline assessment (T3), 32 weeks after baseline assessment (T4)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07444866, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in